Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
Browse by Speaker
Home
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
D
Dasari , Samyuktha
TruSight Oncology Portfolio IVD and RUO Expansion
Location: Innovation Spotlight Stage #1
Samyuktha Dasari
David, Marjorie
UT Health San Antonio
Case Studies in Solid Tumors II
Location: 118 - 120, Level 1
Marjorie David
Davis, Abigail
Mastering Quality Management Systems: Ensuring Compliance with the New FDA LDT Rule
Location: 202 - 204, Level 2
Abigail Davis
Davis, Darren
Molecular Profiling in Difficult Samples From NSCLC Quickly and Cost-Effectively
Location: 114 & 115, Level 1
Darren Davis
Dee, Edward Christopher
Memorial Sloan Kettering Cancer Center, Department of Radiation Oncology
Global Disparities in Genetic Testing and Molecular Diagnostics for Cancer: Charting an Equitable Path Forward
Location: 211 - 214, Level 2
Edward Christopher Dee
Deignan, Josh
Department of Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA,
Laboratory Considerations for the Incidental Detection of Acquired Variants in Germline Genetic Testing
Location: 109 & 110, Level 1
Josh Deignan
Demers, Ryan
AstraZeneca
Strategic Collaborations for Expanding Liquid Biopsy Use Globally
Location: 214, Level 2
Ryan Demers
Deptula, Leanne
Versiti
Fireside Chat: LDT Compliance in an Uncertain Environment
Location: 211, Level 2
Leanne Deptula
Dickey, Jennifer
Personal Genome Diagnostics
Panel Discussion: Bridging the Gaps Towards Implementing Minimal Residual Disease in Clinical Practice – A Collaborative View Across the Healthcare Ecosystem
Location: 118, Level 1
Jennifer Dickey
Diehl, Paul
TCR & BCR Repertoire Profiling, Functional Screens & Other Approaches for Drug Target & Biomarker Identification & Validation
Location: 208 & 209, Level 2
Paul Diehl
Dillon, Laura
NIH
(H036) FNIH MRD in AML Biomarkers Consortium: Evaluation of Methods for Detection of FLT3 Internal Tandem Duplication Measurable Residual Disease in Acute Myeloid Leukemia
Location: 211 - 214, Level 2
Laura Dillon
Ding, Yi
Geisinger Medical Center
Molecular at Home and Point of Care Testing for Infectious Diseases
Location: 301 - 305, Level 3
Yi Ding
Dowlati, Ramin
Johnson & Johnson
Panel Discussion: Bridging the Gaps Towards Implementing Minimal Residual Disease in Clinical Practice – A Collaborative View Across the Healthcare Ecosystem
Location: 118, Level 1
Ramin Dowlati
Drendel, Holli
Atrium Health
Precision Oncology in Action: NGS Workflows, Multi-Site Clinical Genomic Reporting, and Organization-Wide Integration at Atrium Health
Location: 221 & 222, Level 2
Holli Drendel
Duddalwar, Vinay
USC Keck School of Medicine
Radiogenomics: Integrating Molecular and Imaging Data in Cancer Diagnosis
Location: 118 - 120, Level 1
Vinay Duddalwar
